The FY25 Highlights report from Vanderbilt University's Center for Technology Transfer and Commercialization (CTTC) showcases strong performance in technology transfer, intellectual property development, and commercialization activities for Fiscal Year 2025, with comparisons to three-year averages and a comprehensive 10-year snapshot (FY16–FY25).
Key FY25 Achievements:
- Intellectual Property: 53 U.S. patents issued, 284 U.S. patent applications filed, 231 new invention disclosures, 519 individual Vanderbilt submitters, 197 first-time submitters, 80 departments/divisions/institutes/centers engaged, and 1,031 material transfer agreements reviewed.
- Innovation & Commercialization Impact: 104 licenses and options executed, 278 end-user transactions, 54 confidential disclosure agreements, $13.6 million in revenue generated, $32.8 million in sponsored research related to licensed technologies, 207 sponsored research collaboration agreements reviewed, 16 Vanderbilt-affiliated new ventures launched, and 29 clinical trial agreements reviewed.
10-Year Snapshot (FY16–FY25):
- 1,887 inventions disclosed
- 611 U.S. patents issued
- 929 licenses executed
- $305.1 million in total revenue generated
- 66 startups launched
Research Funding Context (FY16–FY25):
- $9.69 billion in total research expenditures
- $670 million in industry-sponsored research
- $5.99 billion in federal research funding
The report also includes trend graphs showing steady growth in licenses/options and material transfer/sponsored research agreements over the decade, reflecting CTTC's ongoing success in translating Vanderbilt research into real-world impact.